Work

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

Year: 2012

Type: article

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2012.09.002

Authors: Martin Reck, Nick Thatcher, Egbert F. Smit, Paul Lorigan, Ewa Szutowicz-Zielinska, Astra M. Liepa, Katherine B. Winfree, Patrick Peterson, Susan C. Guba, Mark A. Socinski

Institutions: LungenClinic Grosshansdorf, The Christie Hospital, Amsterdam UMC Location Vrije Universiteit Amsterdam, Gdańsk Medical University, Eli Lilly (United States), University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2058165225

FWCI: 0.79

Cites: 24

Cited by: 34

Related to: 10